Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Viela Bio
Biotech
Horizon inks $3B deal to buy AstraZeneca spinout Viela
The takeover will give Horizon a clutch of clinical-phase autoimmune and inflammatory disease candidates, R&D capabilities and an approved antibody.
Nick Paul Taylor
Feb 1, 2021 8:55am
Roche's satralizumab cuts relapse risk in rare disease phase 3
Sep 12, 2019 7:50am
AstraZeneca spinout Viela lines up $150M IPO
Aug 30, 2019 8:40am
AstraZeneca spinout Viela bags $75M as FDA filing nears
Jun 18, 2019 8:50am
Viela Bio, China's Hansoh pen $220M-plus development deal
May 28, 2019 10:58am
Chugai ponies up $1B+ to combine R&D in Yokohama
May 22, 2019 10:33am
